Ying Lin
Ying Lin
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation | HRR Gene Mutation; Her-2 Negative Breast Cancer | Recruiting | Phase 2 | 2023-03-09 | NCT05761470 |